It is a unified system for registering medical products (human medicines – medical devices – veterinary medicines) in the GCC Health Council, to ensure the quality, effectiveness and safety of the medical product, and the accuracy of information related to it, and that it is manufactured in accordance with international specifications and standards. It is considered one of the most important goals that the central Gulf committees seek to register medical products to achieve are:
Unifying systems and procedures related to the process of registering medical companies and their products in the GCC countries. It also aims to ensure the application of the principles of good manufacturing of medical products, standardize the pricing of drugs marketed in the GCC countries, activate the post-marketing follow-up program for medical products related to quality and side effects of products, which increases integration. And coordination among member states in the field of medical products. The Gulf Products Classification Committee also carries out the classification process based on unified definitions and standards.
It is a unified system for drug registration in the GCC Health Council, to ensure the quality, effectiveness and safety of the drug, and the accuracy of information related to it, and that it is manufactured in accordance with international specifications and standards. This system aims to:
Unifying the pricing of medicines that are marketed in the GCC countries
Unifying the registration of pharmaceutical companies in the GCC countries
Standardization of systems and procedures in the process of registering pharmaceutical companies and medicines
Increasing integration and coordination among member states in the pharmaceutical field
Standardization of information and conditions when registering medicines
Ensuring the application of the principles of good manufacturing by companies
Access to safe and effective medicine at reasonable prices
Using the drug optimally and at the lowest cost
Follow-up of medicines in terms of quality and side effects
It is the committee that was approved to carry out the central drug registration for the countries of the Cooperation Council according to Resolution No. (6) at the forty-fifth conference, which was held in Geneva (Switzerland) in May 1998.
Two members from each country
The committee is chaired by one of the member states, and it rotates every year according to the Health Council meetings system
The committee holds (12) meetings, including (6) meetings that take place via conference call between technicians in the countries to study the registration files in the member states.
It is the committee that works to register medical devices and supplies in accordance with international standards. The committee verifies the safety, effectiveness and efficiency of medical devices.
The committee was formed by a decision of the Ministers in the forty-second session of the Council of Ministers of Health by circulation
The members of the committee study all files related to medical devices and companies’ requests in accordance with the scientific and international foundations in registration. They also constantly develop the registration process according to international amendments and developments in this context. The committee meets six times a year
It is the committee that was approved to do the pricing of pharmaceutical preparations for the GCC countries, according to the following:
Two members from each country. The committee is chaired by one of the member states, alternately every year, according to the Health Council meetings system
The Committee meets regularly throughout the year, approximately every three months, in one of the GCC countries, alternately
Establishing a unified electronic system for product classification in the GCC countries
Standardization of definitions and criteria for classification of products
Classification of products centrally at the level of the Gulf Cooperation Council countries